書報討論
| 報告日期 | 報告題目 | 報告人 | |
|---|---|---|---|
| 2026-05-22 | AI-assisted Drug Repurposing Identifies FDA-approved Inhibitors Targeting KrasG12D in Pancreatic Ductal Adenocarcinoma | 林思蓉 | |
| 2026-05-22 | Therapeutic Effects of Dual Suicide Gene System in Drug-resistant Glioma Cells and Development of a Survivin-Targeted RCR Vector | 陳塏倢 | |
| 2026-05-15 | TGFBI integrates desmoplasia-driven mechanotransduction to promote metastatic progression in pancreatic ductal adenocarcinoma | 施姵辰 | |
| 2026-05-15 | Lactose-Modified Chitosan Nanoparticles for Targeted Antimicrobial Peptide Delivery Against Candida albicans and Associated Biofilm Infections | 周義盛 | |
| 2026-05-15 | HDAC6 Defines a Chemotherapy-activated Stromal Program that Promotes CXCL12-driven Metastasis in Pancreatic Ductal Adenocarcinoma | 方淑怡 | |
| 2026-05-08 | 探討多形性膠質母細胞瘤對Temozolomide 之化療抗藥性主要源自於癌細胞中MGMT基因的高度表現 | 鄭恩慈 | |
| 2026-05-08 | Effects of Octapeptide Repeat Copy Number on the Aggregation and Condensation Behavior of the Prion Protein | 蔣嘉翰 | |
| 2026-05-08 | The Improvement of Polyunsaturated Fatty Acid Biosynthesis | 何宗穎 | |
| 2026-04-24 | Neolactotetraosylceramide enables urinary detection of bladder cancer | Shanmathi Sivalingam | |
| 2026-04-24 | Understanding Biases in Liquid−Liquid Phase Separation: Investigating Amino Acid Enrichments in Phase-Separating Proteins toward Peptide Design | 陳保良 | |
| 2026-04-24 | α-ketoglutarate/succinate ratio imbalance impairs thymine DNA glycosylase function and base excision repair process increasing susceptibility to pancreatic cancer | 劉芷亭 | |
| 2026-04-24 | α-ketoglutarate/succinate ratio imbalance impairs thymine DNA glycosylase function and base excision repair process increasing susceptibility to pancreatic cancer | 劉芷亭 | |
| 2026-04-24 | α-ketoglutarate/succinate ratio imbalance impairs thymine DNA glycosylase function and base excision repair process increasing susceptibility to pancreatic cancer | 劉芷亭 | |
| 2026-04-17 | Enhanced RNA-targeting CRISPR-Cas technology in zebrafish | 温仁育 | |
| 2026-04-17 | BCL-xL as a Therapeutic Target in Cetuximab-Refractory Colorectal Cancer | 黃宥蓁 | |
| 2026-03-27 | Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial | 邱思晴 | |
| 2026-03-27 | USP15 regulates radiation-induced DNA damage and intestinal injury through K48- linked deubiquitination and stabilisation of ATM | 張哲維 | |
| 2026-03-27 | Remodeling of T and endothelial cells during total neoadjuvant therapy in rectal cancer | 周嘉慧 | |
| 2026-03-20 | HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy | 邵小嘉 | |
| 2026-03-20 | Innovative dual-gene delivery platform using miR-124 and PD-1 via umbilical cord mesenchymal stem cells and exosome for glioblastoma therapy | 張洛薇 | |
| 2026-03-20 | Whole-genome landscapes of 1,364 breast cancers | 張于婷 | |
| 2026-03-13 | CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells | 呂祥瑜 | |
| 2026-03-13 | argeting aryl hydrocarbon receptor functionally restores tolerogenic dendritic cells derived from patients with multiple sclerosi | 高士耕 | |
| 2026-03-13 | “Sample-in, result-out” liquid biopsy chip based on immunomagnetic separation and CRISPR detection for multiplex analysis of exosomal microRNAs | 吳柏嶔 | |
| 2026-03-13 | Galectin-3 exacerbates autoimmune diabetes by limiting regulatory T cell differentiation and function | 劉千瑜 |
